Editorial Commentary: Short‐Course Treatment of Community‐Acquired Pneumonia
Author:
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Link
http://academic.oup.com/cid/article-pdf/37/6/761/846256/37-6-761.pdf
Reference10 articles.
1. Effect of Short-Course, High-Dose Amoxicillin Therapy on Resistant Pneumococcal Carriage
2. High‐Dose, Short‐Course Levofloxacin for Community‐Acquired Pneumonia: A New Treatment Paradigm
3. Randomized, Multicentre Study of the Efficacy and Tolerance of Azithromycin versus Clarithromycin in the Treatment of Adults with Mild to Moderate Community-Acquired Pneumonia
4. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin–clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome
5. Tellier G, Isakov T, Petermann W, Patel M, Lavin B. Efficacy and safety of telithromycin (800 mg once daily) for 5 or 7 days vs clarithromycin (500 mg twice daily) for 10 days in the treatment of patients with community acquired pneumonia [abstract L-373]. In: Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002:346.
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients;Cochrane Database of Systematic Reviews;2018-09-06
2. Proposal for shorter antibiotic therapies;Médecine et Maladies Infectieuses;2017-03
3. Community-Acquired Pneumonia;New England Journal of Medicine;2014-10-23
4. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia;Respirology;2011-06-28
5. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients;Cochrane Database of Systematic Reviews;2011-04-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3